近亿元融资！血管介入创新企业完成B+轮

Group 1 - The core viewpoint of the article highlights the recent completion of nearly 100 million RMB in B+ round financing by Koser Medical Technology (Suzhou) Co., Ltd., aimed at product development, global market promotion, and capacity expansion [1] - Koser Medical, established in 2013, operates as a platform enterprise in the vascular interventional device sector, employing a "one core, three wings" strategy to cover various treatment areas [2] - The company has developed a comprehensive treatment system for peripheral intervention and has subsidiaries focusing on cardiac electrophysiology, coronary intervention products, and core medical material technologies [2] Group 2 - Koser Medical has invested over 300 million RMB in R&D, building a robust technology platform with hundreds of domestic and international patents, including nearly 100 PCT patents [5] - The company has successfully commercialized innovative products, including the first registered umbrella-shaped long-term filter in China and balloon products that have received multiple international certifications [5] - Koser Medical's products are utilized in approximately 2000 hospitals in China and have been registered in over 20 countries internationally [5] Group 3 - The financing history of Koser Medical includes several rounds, with significant investments from various venture capital firms, culminating in the recent B+ round led by Tietou Jushi [4][5] - The company has seen a progressive increase in funding, starting from several million RMB in Pre-A round financing in early 2017 to nearly 100 million RMB in the latest B+ round [4][5]